Schreiner MediPharm’s High-Tech Digital Adherence Monitoring Solution Wins FINAT Award

Smart Blister Card enables real-time tracking of medication intake and patient adherence

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • The data is then stored in the Smart Blister Card and transmitted to a database via a smartphone app or a reader using NFC or Bluetooth technology.
  • Once the patient pushes a tablet out of a cavity, data is generated in real time and includes information such as the exact time of pill removal, the respective cavity, and the dose it contains.
  • After filling and sealing the blister pack, the Smart Blister Card is simply attached to the back of the pack without impairing the filling process.

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, won a prestigious award for its Smart Blister Card from the European Association of the Self-Adhesive Label Industry (FINAT), which recognizes the industry’s best products. The Smart Blister Card, which extends standard multi-dose blister packs by a digital adherence monitoring tool enabling tracking of medication intake in real time, received the top honor in the “Innovation & Electronic Printing – Electronic Devices” category.

In the case of polypharmaceutical applications (permanent therapies involving the simultaneous prescription of several medications), pills are frequently filled into standard blister packs by hospital and large pharmacies so that patients can take them according to their medication plans. However, physicians and pharmacies typically have no way of tracking whether and when patients have taken their medicines. Schreiner MediPharm’s Smart Blister Card tackles this challenge by enabling digital medication adherence monitoring.

Integrated into the Smart Blister Card are conductive lines combined with an electronic unit. Once the patient pushes a tablet out of a cavity, data is generated in real time and includes information such as the exact time of pill removal, the respective cavity, and the dose it contains. The data is then stored in the Smart Blister Card and transmitted to a database via a smartphone app or a reader using NFC or Bluetooth technology.

For physicians and pharmacists, the handling of the Smart Blister Card is both convenient and flexible. After filling and sealing the blister pack, the Smart Blister Card is simply attached to the back of the pack without impairing the filling process. The technology can be inconspicuously integrated into the packaging design, and the marking of each cavity remains clearly visible. In addition, a temperature monitoring feature for sensitive ingredients is an available option.

The Smart Blister Card is suitable for nearly all existing multi-dose and single-dose blister packs. Patients can take their pills as usual because the cavities can be pushed through as easily as before. Additionally, smartphone apps can provide patients with digital self-monitoring support and even enable a reminder function to comply with their medication plan. Thus, Schreiner MediPharm’s Smart Blister Card helps enhance therapeutic success in polypharmaceutical applications.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance

"We are thrilled with the DEA's decision, which underscores the potential of MIRA-55 as a groundbreaking therapeutic candidate," said Erez Aminov, Chairman & CEO of MIRA Pharmaceuticals. "This ruling allows us to focus on MIRA-55's unique cognitive and anxiety benefits. With access to $90B traditional neurological and $30B cannabis markets, MIRA-55 represents a significant value proposition for our company.  We remain committed to advancing it through the development pipeline for treating these diseases from which so many currently suffer."

Abu Dhabi Issues First BioTech Inventor-Class Golden Visa to Catalyze “Made-In-Abu-Dhabi IP” to Rockefeller University Inventor Dr Kambiz Shekdar, PhD

Dr Kambiz Shekdar said: "I gratefully take this opportunity as my solemn commitment to help build up the BioTech sector in Abu Dhabi with the same home-grown can-do-and-have-done record of accomplishment demonstrated by Emirati leadership, its people, and nation, and to do so collegially with the best of the best of the world's human capital across frontier technologies who, like myself, are drawn to the UAE with the thirst to pioneer and build better like only possible in the red-hot entrepreneurial climate of the UAE."

Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startups

"We celebrate the growing base of research and technological advances within the region's health and life sciences sector," said Chandra Briggman, President and CEO of Activation Capital.

By using this website you agree to accept Medical Device News Magazine Privacy Policy